We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HBIO market cap is 167.09M. The company's latest EPS is USD -0.0787 and P/E is -49.17.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 27.16M | 28.43M | 29.98M | 28.76M | 25.36M |
| Operating Income | -3.76M | -457k | 1.75M | 796k | -933k |
| Net Income | -3.41M | -1.67M | 622k | -980k | -1.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 116.18M | 102.1M | 118.9M | 113.57M | 112.25M |
| Operating Income | 1.84M | 221k | 2.07M | -6.93M | 1.89M |
| Net Income | -4.69M | -7.81M | -288k | -9.52M | -3.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 147.01M | 145.36M | 145.58M | 142.9M | 139.74M |
| Total Liabilities | 75.03M | 73.14M | 71.24M | 67.51M | 65.45M |
| Total Equity | 71.98M | 72.22M | 74.34M | 75.39M | 74.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 164.87M | 156.25M | 162.34M | 145.36M | 137.37M |
| Total Liabilities | 83.18M | 79.57M | 78.94M | 73.14M | 64.29M |
| Total Equity | 81.69M | 76.68M | 83.4M | 72.22M | 73.07M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.53M | 1.15M | 1.81M | 5.36M | 9.73M |
| Investing | -1.36M | -1.59M | 288k | -337k | -738k |
| Financing | -107k | -2.84M | -2.89M | -5.27M | -8.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.05M | 9.33M | 1.26M | 1.15M | 14.03M |
| Investing | -229k | -1.4M | -1.35M | -1.59M | -1.8M |
| Financing | -7.62M | -7.97M | -252k | -2.84M | -12.13M |
| Market Cap | 167.09M |
| Price to Earnings Ratio | -49.17 |
| Price to Sales Ratio | 1.5 |
| Price to Cash Ratio | 39.21 |
| Price to Book Ratio | 2.3 |
| Dividend Yield | - |
| Shares Outstanding | 43.4M |
| Average Volume (1 week) | 140.28k |
| Average Volume (1 Month) | 106.75k |
| 52 Week Change | -37.40% |
| 52 Week High | 6.2797 |
| 52 Week Low | 3.44 |
| Spread (Intraday) | 0.97 (21.37%) |
| Company Name | Harvard Bioscience Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.harvardbioscience.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
